Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sj&#xf6;gren&apos;s syndrome: A Danish cohort study

Autoimmune Disease

The Impact of IgG Fc-Glycosylation on Disease Dynamics in Primary Sjögren's Disease- Insights from the Belgian Sjögren's Syndrome Transition Trial

Arthritis Rheumatol

Achten H, Meuris L, Deroo L, Jarlborg M, Decruy T, Deprez J, Dumas E, De Boeck K, Genbrugge E, Bauters W, Dochy F, Creytens D, Roels D, Callewaert N, Elewaut D, Peene I

doi: 10.1002/art.43018

Further Publications Immunology

Patients' recollection about the onset of Sjögren's disease - a mixed methods study on the patients' perspective

Arthritis Res Ther

Lackner A, Dreo B, Hermann J, Zenz S, Fessler J, Thiel J, Stradner MH

doi: 10.1186/s13075-024-03404-8

Autoimmune Disease

Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study

Lancet

Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W, TWINSS study group

doi: 10.1016/S0140-6736(24)01211-X

Autoimmune Disease

A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren's disease

Ann Rheum Dis

Tsaliki M, Cavett J, Kurien BT, Bruxvoort C, Lewis VM, Ice JA, Dave D, Khosravani S, Grundahl K, Lessard CJ, Rasmussen A, Sivils KL, Farris AD, Koelsch KA, Scofield RH

doi: 10.1016/j.ard.2025.03.012

Autoimmune Disease

Mortality in patients with Sjögren Disease: A Prospective Cohort Study Identifying Key Predictors

J Rheumatol

Lovgach OR, Plaza Z, Fernández Castro M, Rosas J, Martínez-Taboada V, Olivé A, Menor Almagro R, Serrano Benavente B, Font-Urgelles J, Garcia-Aparicio A, Manrique-Arija S, Garcia-Vadillo JA, Lopez-Gonzalez R, Narvaez García J, Rodriguez-Lozano MB, Galisteo C, Gonzalez-Martin JJ, Vela-Casasempere P, Bohorquez C, Erausquin C, Paredes-Romero MB, Riancho-Zarrabeitia L, Diaz SM, Pego-Reigosa JM, Heredia S, Moriano C, Blazquez Cañamero MA, Estrada P, Judez E, Belzunegui Otano J, Ramos Giráldez C, Domínguez Álvaro M, Sánchez Alonso F, Andréu Sánchez JL

doi: 10.3899/jrheum.2024-1033

Autoimmune Disease

Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study

Rheumatology (Oxford)

Tison A, Jousse-Joulin S, Consigny M, Moog P, Hofauer B, Hachulla E, Lamotte C, Morel J, Mouterde G, Milic V, Bootsma H, Stel A, Fisher BA, Maybury M, Baer A, DiRenzo D, Kim HR, Min HK, Lee SS, Choi SE, Alegria GC, Boisramé S, Guellec D, Cornec D, Quéré B, Jonsson M, Hammenfors D, Saraux A, Devauchelle-Pensec V

doi: 10.1093/rheumatology/keae690

Autoimmune Disease

A systematic review of clinical trial designs and outcome measures in Sjögren's disease randomized trials

J Rheumatol

Beydon M, Nguyen Y, Gordon R, Foulquier N, Bouillot C, Hammitt KM, Bowman SJ, Mariette X, Cornec D, McCoy SS, Seror R

doi: 10.3899/jrheum.2024-1012

Immunotherapy

Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren's disease

Ann Rheum Dis

Meudec L, Goudarzi N, Silva-Saffar SE, Pascaud J, Jaulin F, Pascal Q, Lazure T, Bechara R, Mariette X, Nocturne G

doi: 10.1016/j.ard.2025.04.020

Systemic Lupus Erythematosus

Incidence and risk of arterial and venous thrombotic events in Systemic Lupus Erythematosus patients: a population-based study

Rheumatology (Oxford)

Ojeda-Fernandez L, Calvisi S, Torrigiani G, Tettamanti M, Fortino I, Roncaglioni C, Baviera M

doi: 10.1093/rheumatology/keae496

Dermatology · Immunology · Rheumatology

Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sjögren's syndrome: A Danish cohort study

Related content

The Impact of IgG Fc-Glycosylation on Disease Dynamics in Primary Sjögren's Disease- Insights from the Belgian Sjögren's Syndrome Transition Trial

Patients' recollection about the onset of Sjögren's disease - a mixed methods study on the patients' perspective

Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study

A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren's disease

Mortality in patients with Sjögren Disease: A Prospective Cohort Study Identifying Key Predictors

Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study

A systematic review of clinical trial designs and outcome measures in Sjögren's disease randomized trials

Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren's disease

Incidence and risk of arterial and venous thrombotic events in Systemic Lupus Erythematosus patients: a population-based study